Ivermectin should be looked at more. It helps with long Covid as well as active and as a
preventative measure (though I would not expect many people outside of medical workers to take a daily preventive dose of anything for a virus, still just interesting).<p>It’s out of patent and there’s no almost money to be made providing it, so drug companies and organizations they have captured (WHO, CDC, NYT, YouTube, to name a few) are shutting down discussion of it.<p>By “shutting down discussion” I mean for example literally deleting video of Senate testimony from a practicing ICU doctor (Pierre Kory) whose protocols have been widely adopted for Covid treatment.<p>In a trial of ~1200 health care workers who were working closely with Covid patients, 800 who received prophylactic ivermectin had zero cases of Covid. Of the 350+ (the numbers did not add up to exactly 1200) workers who received a placebo, 57% of them did get Covid.<p>That’s just a trial. There are also real world use results. There are many successful trials of it, but big pharma is promoting the (possibly valid) criticism that the studies are not randomized enough. I don’t know if this applies to all studies, but it’s a propaganda war, so I’d fully expect they’ll make it sound like it does. Another captured organization (sorry, forgot the name) claimed that they worried there might be publication bias in the studies, but this has been
looked at and ruled out.<p>In real life, it’s been used in several large countries to bring crises under control… on a nationwide basis in Mexico and more spotilly on a state by state basis in India (politics comes in and when something works, others with opposed interests work to suppress the good news and make noise to sow FUD… which is supposedly part of why the overwhelmingly positive Mexico results have not been huge in the news).<p>It’s also been around for decades as an anti-parasite drug and is known to be safe in adults and children. And it has anti inflammatory effects that also help when used to fight an active Covid case. Worth some attention at least.